Regulation of the inflammatory response by tin protoporphyrin IX in the rat anterior cruciate ligament transection model of osteoarthritis

Journal of Orthopaedic Research

Volumn 29, Issue 9, 2011, Pages 1375-1382

  Braza Boïls, Aitana ^a   Alcaraz, Maria José ^a   Ferrándiz, Maria Luisa ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

animal model; anterior cruciate ligament transection; inflammation; osteoarthritis; tin protoporphyrin IX

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE 2; CYCLOOXYGENASE 2; HYALURONIC ACID; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROSTAGLANDIN E2; PROTOPORPHYRIN TIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; DOWN REGULATION; INFLAMMATION; MALE; NONHUMAN; OSTEOARTHRITIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TREATMENT DURATION;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CYTOKINES; DINOPROSTONE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; MALE; METALLOPORPHYRINS; OSTEOARTHRITIS; PROTOPORPHYRINS; RATS; RATS, WISTAR; STIFLE;

EID: 79960231236     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21411     Document Type: Article

References (34)

1. Abramson SB, Attur M, Yazici Y,. 2006. Prospects for disease modification in osteoarthritis. Nat Clin Pract Rheumatol 2: 304-312. (Pubitemid 43842259)
2. Gelber AC, Hochberg MC, Mead LA, et al. 2000. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med 133: 321-328.
3. Aigner T, Soder S, Gebhard PM, et al. 2007. Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis-structure, chaos and senescence. Nat Clin Pract Rheumatol 3: 391-399. (Pubitemid 47034540)
4. Hayami T, Pickarski M, Zhuo Y, et al. 2006. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 38: 234-243. (Pubitemid 43165790)
5. Stoop R, Buma P, van der Kraan PM, et al. 2001. Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats. Osteoarthritis Cartilage 9: 308-315. (Pubitemid 32457789)
6. Appleton CT, Pitelka V, Henry J, et al. 2007. Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum 56: 1854-1868. (Pubitemid 47110385)
7. Setton LA, Elliott DM, Mow VC,. 1999. Altered mechanics of cartilage with osteoarthritis: human osteoarthritis and an experimental model of joint degeneration. Osteoarthritis Cartilage 7: 2-14. (Pubitemid 29112956)
8. Garnero P, Piperno M, Gineyts E, et al. 2001. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 60: 619-626. (Pubitemid 32493990)
9. Clark AG, Jordan JM, Vilim V, et al. 1999. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum 42: 2356-2364. (Pubitemid 30333416)
10. Elliott AL, Kraus VB, Luta G, et al. 2005. Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum 52: 105-111. (Pubitemid 40129238)
11. Livshits G, Zhai G, Hart DJ, et al. 2009. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study. Arthritis Rheum 60: 2037-2045.
12. Rooney T, Roux-Lombard P, Veale DJ, et al. 2009. Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression. analysis of a proof-of-concept randomized clinical trial of cytokine blockade. Ann Rheum Dis 69: 706-714.
13. Fernandes JC, Martel-Pelletier J, Pelletier JP,. 2003. The role of cytokines in osteoarthritis pathophysiology. Biorheology 39: 237-246. (Pubitemid 34626067)
14. Devesa I, Ferrandiz ML, Terencio MC, et al. 2005. Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis. Arthritis Rheum 52: 3230-3238. (Pubitemid 41447106)
15. Devesa I, Ferrándiz ML, Guillén I, et al. 2005. Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis. Lab Invest 85: 34-44. (Pubitemid 40128039)
16. Pritzker KP, Gay S, Jimenez SA, et al. 2006. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 14: 13-29. (Pubitemid 43034086)
17. Moroney MA, Alcaraz MJ, Forder RA, et al. 1988. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J Pharm Pharmacol 40: 787-792.
18. Bradford MM,. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
19. Dam EB, Byrjalsen I, Karsdal MA, et al. 2009. Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI. Osteoarthritis Cartilage 17: 384-389.
20. Vilim V, Olejarova M, Machacek S, et al. 2002. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 10: 707-713. (Pubitemid 34993958)
21. Arai K, Tagami M, Hatazoe T, et al. 2008. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fluid, serum and urine from 51 racehorses with carpal bone fracture. J Vet Med Sci 70: 915-921.
22. Hayami T, Pickarski M, Wesolowski GA, et al. 2004. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 50: 1193-1206. (Pubitemid 38480830)
23. Nielsen RH, Stoop R, Leeming DJ, et al. 2008. Evaluation of cartilage damage by measuring collagen degradation products in joint extracts in a traumatic model of osteoarthritis. Biomarkers 13: 79-87.
24. Pruksakorn D, Rojanasthien S, Pothacharoen P, et al. 2009. Chondroitin sulfate epitope (WF6) and hyaluronic acid as serum markers of cartilage degeneration in patients following anterior cruciate ligament injury. J Sci Med Sport 12: 445-448.
25. Daniel DM, Stone ML, Dobson BE, et al. 1994. Fate of the ACL-injured patient. A prospective outcome study. Am J Sports Med 22: 632-644. (Pubitemid 24280036)
26. Jean YH, Wen ZH, Chang YC, et al. 2007. Intra-articular injection of the cyclooxygenase-2 inhibitor parecoxib attenuates osteoarthritis progression in anterior cruciate ligament-transected knee in rats: role of excitatory amino acids. Osteoarthritis Cartilage 15: 638-645.
27. Martin JA, Brown T, Heiner A, et al. 2004. Post-traumatic osteoarthritis: the role of accelerated chondrocyte senescence. Biorheology 41: 479-491. (Pubitemid 39277104)
28. Pelletier JP, Martel-Pelletier J, Abramson SB,. 2001. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 44: 1237-1247. (Pubitemid 32537520)
29. Goldring SR, Goldring MB,. 2004. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 427: 527-536.
30. Kugisaki H, Sonohata M, Komine M, et al. 2009. Serum concentrations of interleukin-6 in patients following unilateral versus bilateral total knee arthroplasty. J Orthop Sci 14: 437-442.
31. Pappu R, Ramirez-Carrozzi V, Ota N, et al. 2010. The IL-17 family cytokines in inmunity and disease. J Clin Inmunol 30: 185-195.
32. Wittenberg RH, Willburger RE, Kleemeyer KS, et al. 1993. In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum 36: 1444-1450. (Pubitemid 23304215)
33. 2 production. J Pharmacol Exp Ther 283: 1069-1075. (Pubitemid 28016478)
34. Attur M, Al Mussawir HE, Patel J, et al. 2008. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol 181: 5082-5088.